마이크로 봉합사 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 수술별, 최종 용도별, 재료별, 지역별, 부문별 예측(2025-2030년)

Microsutures Market Size, Share & Trends Analysis Report By Product (Absorbable, Non-Absorbable), By Surgery (General Surgery, Ophthalmology, Neurosurgery), By End Use, By Material (Nylon, Polydioxanone), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,641,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,094,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,998,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

마이크로 봉합사 시장 요약

마이크로 봉합사 세계 시장 규모는 2024년에 3억 1,000만 달러로 평가되며 2025년부터 2030년까지 3.31%의 CAGR로 성장하여 2030년에는 3억 8,000만 달러에 달할 것으로 예상됩니다. 이러한 시장 성장의 주요 요인은 최소침습 수술 기술의 발전, 정밀한 상처 관리가 필요한 만성질환의 증가, 의료 관광의 증가 등입니다.

미용 성형 및 재건 수술에 대한 수요가 증가함에 따라 미세하고 눈에 잘 띄지 않는 봉합을 용이하게 하고 더 나은 미적 결과를 제공하는 마이크로 봉합사의 채택을 더욱 촉진하고 있습니다. 또한 생분해성 봉합사, 고강도 봉합사 등 봉합사 소재의 기술 혁신은 수술의 효율성과 안전성을 향상시켜 그 보급을 촉진하고 있습니다. 주로 미용성형, 성형외과 등의 수술 건수가 증가하고 있는 것이 시장의 수요를 촉진하고 있습니다. 예를 들어, Global Survey 2023이 발표한 데이터에 따르면 2023년 가장 많이 시행된 수술은 지방흡입술로 220만 건 이상이었으며, 가슴성형, 눈꺼풀 수술, 복부 성형술, 코 성형술이 그 뒤를 이었습니다. 이러한 수술의 증가는 상처 봉합과 수술 후 회복에 중요한 역할을 하는 봉합사 수요에 직접적인 영향을 미칩니다.

봉합사 수요는 미용 성형 수술 외에도 제왕절개, 성형 수술, 심혈관 수술 등 필수적인 의료 시술에 의해 촉진되어 시장의 성장 가능성을 더욱 확대시키고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 마이크로 봉합사 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 세계의 마이크로 봉합사 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 가격 분석
  • 파이프라인 분석

제4장 세계의 마이크로 봉합사 시장 : 제품 추정·동향 분석

• 세계의 마이크로 봉합사 시장 : 제품 대시보드
• 세계의 마이크로 봉합사 시장 : 제품 변동 분석
• 제품별, 수익별
• 흡수성
• 비흡수성

제5장 세계의 마이크로 봉합사 시장 : 수술 추정·동향 분석

• 세계의 마이크로 봉합사 시장 : 수술 대시보드
• 세계의 마이크로 봉합사 시장 : 수술 변동 분석
• 수술별, 수익별
• 일반외과
• 안과
• 성형외과 및 재건외과
• 신경외과
• 심혈관외과
• 이식
• 부인과 수술
• 기타

제6장 세계의 마이크로 봉합사 시장 : 최종 용도 추정·동향 분석

• 세계의 마이크로 봉합사 시장 : 최종 용도 대시보드
• 세계의 마이크로 봉합사 시장 : 최종 용도 변동 분석
• 최종 용도별, 수익별
• 병원
• 외래 수술 센터(ASC)
• 전문 클리닉
  • 안과·안과 외과 클리닉
  • 불임 치료 클리닉
  • 성형외과 클리닉
  • 치과의원
• 기타

제7장 세계의 마이크로 봉합사 시장 : 재료 추정·동향 분석

• 세계의 마이크로 봉합사 시장 : 재료 대시보드
• 세계의 마이크로 봉합사 시장 : 재료 변동 분석
• 세계의 마이크로 봉합사 시장(재질별, 수익별)
• 나일론
• 폴리글리콜산(PGA)
• 폴리디옥사논
• 기타

제8장 세계의 마이크로 봉합사 시장 : 지역 추정·동향 분석, 제품별, 수술별, 최종 용도별

• 지역 대시보드
• 시장 규모와 예측 동향 분석, 2018년부터 2030년까지 :
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 주요 시장 진입 기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 상황
  • 주요 판매대리점 및 채널 파트너 리스트
  • Key customers
  • Key company market share analysis, 2024
  • Corza Medical
  • Baxter
  • AD Surgical
  • Ethicon(Johnson & Johnson)
  • Kono Seisakusho Group
  • Suturex
  • AROSurgical Instruments
  • Bear Medic Corporation
  • Altomed

ksm

영문 목차

영문목차

Microsutures Market Summary

The global microsutures market size valued at USD 0.31 billion in 2024 and projected to reach USD 0.38 billion by 2030, growing at a CAGR of 3.31% from 2025 to 2030. This market growth is largely attributed to the advancements in minimally invasive surgical techniques, increasing prevalence of chronic diseases requiring precise wound management, and an increase in medical tourism.

The growing demand for cosmetic and reconstructive surgeries further propels the adoption of microsutures due to their ability to facilitate fine, less noticeable stitches, leading to better aesthetic outcomes. In addition, technological innovations in suture materials, such as biodegradable and high-strength sutures, enhance the efficiency and safety of procedures, encouraging their widespread use. The growing number of surgical procedures, mainly cosmetic and plastic surgeries, has resulted in fueling the market demand. For instance, according to the data published by the Global Survey 2023, Liposuction was the most common surgery in 2023, with over 2.2 million, followed by breast augmentation, eyelid surgery, abdominoplasty, and rhinoplasty. All these increased procedures directly influence the demand for sutures, which play a significant role in wound closure and post-surgery recovery.

Beyond cosmetic surgeries, the demand for sutures is also propelled by essential medical procedures such as cesarean sections, orthopedic surgeries, and Cardiovascular Surgery interventions, further expanding the market's growth potential.

Global Microsutures Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2030. For this study, Grand View Research has segmented the global microsutures market report based on product, surgery, end use, material, and region.

• Product Outlook (Revenue, USD Million, 2025 - 2030)
• Absorbable
• Non-absorbable
• Surgery Outlook (Revenue, USD Million, 2025 - 2030)
• General Surgery
• Ophthalmology
• Plastic and Reconstructive Surgery
• Neurosurgery
• Cardiovascular Surgery
• Transplantation
• Gynecological Surgery
• Others
• End Use Outlook (Revenue, USD Million, 2025 - 2030)
• Hospitals
• Ambulatory Surgery Center (ASC)
• Specialty Clinics
  • Ophthalmic and Eye Surgery Clinics
  • Plastic and Reconstructive Surgery Clinics
  • Fertility Clinics
  • Dental Clinics
• Others
• Material Outlook (Revenue, USD Million, 2025 - 2030)
• Nylon
• Polyglycolic Acid (PGA)
• Polydioxanone
• Others
• Regional Outlook (Revenue, USD Million, 2025 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Surgery
  • 1.2.3. End Use
  • 1.2.4. Material
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and Surgery outlook
  • 2.2.2. End Use and Material outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Microsutures Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Microsutures Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Pipeline Analysis

Chapter 4. Global Microsutures Market: Product Estimates & Trend Analysis

• 4.1. Global Microsutures Market: Product Dashboard
• 4.2. Global Microsutures Market: Product Movement Analysis
• 4.3. Global Microsutures Market by Product, Revenue
• 4.4. Absorbable
  • 4.4.1. Absorbable market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Non-Absorbable
  • 4.5.1. Non-absorbable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Global Microsutures Market: Surgery Estimates & Trend Analysis

• 5.1. Global Microsutures Market: Surgery Dashboard
• 5.2. Global Microsutures Market: Surgery Movement Analysis
• 5.3. Global Microsutures Market by Surgery, Revenue
• 5.4. General Surgery
  • 5.4.1. General surgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Ophthalmology
  • 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Plastic and reconstructive surgery
  • 5.6.1. Plastic and reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Neurosurgery
  • 5.7.1. Neurosurgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Cardiovascular surgery
  • 5.8.1. Cardiovascular surgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.9. Transplantation
  • 5.9.1. Transplantation market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.10. Gynecological Surgery
  • 5.10.1. Gynecological Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Global Microsutures Market: End Use Estimates & Trend Analysis

• 6.1. Global Microsutures Market: End Use Dashboard
• 6.2. Global Microsutures Market: End Use Movement Analysis
• 6.3. Global Microsutures Market by End Use, Revenue
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Ambulatory Surgery Center (ASC)
  • 6.5.1. Ambulatory Surgery Center (ASC) market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Specialty Clinics
  • 6.6.1. Ophthalmic and Eye Surgery Clinics
    • 6.6.1.1. Ophthalmic and eye surgery clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.2. Fertility Clinics
    • 6.6.2.1. Fertility clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.3. Plastic and Reconstructive Surgery Clinics
    • 6.6.3.1. Plastic and reconstructive surgery clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6.4. Dental Clinics
    • 6.6.4.1. Dental clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Global Microsutures Market: Material Estimates & Trend Analysis

• 7.1. Global Microsutures Market: Material Dashboard
• 7.2. Global Microsutures Market: Material Movement Analysis
• 7.3. Global Microsutures Market by Material, Revenue
• 7.4. Nylon
  • 7.4.1. Nylon market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Polyglycolic Acid (PGA)
  • 7.5.1. Polyglycolic Acid (PGA) market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Polydioxanone
  • 7.6.1. Polydioxanone market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Global Microsutures Market: Regional Estimates & Trend Analysis, By Product, Surgery, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Corza Medical
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Baxter
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. AD Surgical
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Ethicon (Johnson & Johnson)
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Kono Seisakusho Group
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Suturex
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. AROSurgical Instruments
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Bear Medic Corporation
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Altomed
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives

관련자료